was Like on the weekend, the attorney General, William Tong of Connecticut, a coalition of 44 U.S. States, has filed a lawsuit against Teva Pharmaceuticals and 19 of the largest generic pharmaceutical manufacturers, including Sandoz. Your accusation of conspiracy.
So the corporations have agreed over the years, prices to increase, artificially, and to manipulate. They had reduced the competition and the trade with more than 100 different generic drugs unduly restricted.
The lawsuit was filed in the U.S. District Court for the District of Connecticut. You call also 15 individual Executive defendants, who were in the heart of the conspiracy, for the sales, Marketing, pricing and operation responsible, said a press release of the attorney-General Tong.
"The question drugs to generate several billion dollars in sales in the United States. The alleged plans have led to increased prices, which affected the health insurance market, from the taxpayer-funded health programs such as Medicare and Medicaid, and individuals, the need to artificially pay inflated prices for their prescriptions," according to the press release.
Sandoz under the defendant company
In more than 500 pages long, the indictment also Sandoz. Compared to AWP Novartis confirms that "Sandoz in a industry-wide law, was called to the dispute, to the virtually the entire generic pharmaceutical industry is involved." Novartis believe that the allegations are unfounded and will "contest vigorously". Because Sandoz take your antitrust legal obligations seriously.
According to the indictment, it is alleged that Teva, Sandoz, Mylan, Pfizer, and 16 other manufacturers of generic drugs to a broad-based, coordinated and systematic campaign, carried out in order to join together in order, to set prices, markets, and offers for more than 100 different generic drugs. In some cases, the coordinated price increases, according to the testimony, at about 1'000 per cent.
With the suit to be made for damages, civil penalties and lawsuits of the court to restore competition in the generic market. (nag/sda)
Created: 13.05.2019, 10:28 PM